TD Cowen Remains a Buy on Arcutis Biotherapeutics (ARQT)
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report) today and set a price target of ...
CG Oncology initiated with a Buy at TD Cowen
TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene ...
Nasdaq7d
CG Oncology initiated with a Buy at TD Cowen
TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene is differentiated by its “superior” efficacy and ...